Drugs acting on serotonin receptors for the treatment of functional GI disorders.
about
Comorbidity Factors and Brain Mechanisms Linking Chronic Stress and Systemic IllnessLinaclotide: A new drug for the treatment of chronic constipation and irritable bowel syndrome with constipationRapid anxiolytic effects of a 5-HT₄ receptor agonist are mediated by a neurogenesis-independent mechanismDiagnosis and treatment of chronic constipation--a European perspective.Activation of colonic mucosal 5-HT(4) receptors accelerates propulsive motility and inhibits visceral hypersensitivity.Current and emerging therapies for the management of functional gastrointestinal disorders.New treatments for irritable bowel syndrome in womenNew-generation 5-HT4 receptor agonists: potential for treatment of gastrointestinal motility disorders.Pharmacology of the new treatments for lower gastrointestinal motility disorders and irritable bowel syndrome.New treatment options for chronic constipation: mechanisms, efficacy and safety.Pharmacological therapy of feed intolerance in the critically ills.Influence of a new 5-HT4 receptor partial agonist, YKP10811, on visceral hypersensitivity in rats triggered by stress and inflammation.Mechanisms underlying feed intolerance in the critically ill: implications for treatment.The study on the role of inflammatory cells and mediators in post-infectious functional dyspepsia.Evidence of an enhanced central 5HT response in irritable bowel syndrome and in the rat maternal separation model.Effect of 5-HT4 receptor agonist mosapride citrate on rectosigmoid sensorimotor function in patients with irritable bowel syndrome.
P2860
Q26765501-CE4504E6-D3B1-4A0F-BAF2-A0D8CE839FB1Q33695487-CF90C1D5-418B-452E-8A18-17B0717B562DQ34657940-47545C04-2521-4B8C-B766-4A1C191AFDBCQ35207439-4CE56B34-DB3D-4722-80CE-AB1ADC3BB906Q36336675-9D849264-D0D4-4728-B8A2-3DB413E2E28EQ36443725-703D9DE7-A6BD-4154-9D15-EDA3D47BB907Q37120300-057E1D7A-5074-4941-9221-E56218B8B044Q37735172-42294134-2E7D-4525-9EE3-F3E751704B8AQ37954521-ADB0B3E3-A90D-4252-B73A-0EE16E65CC7EQ37960501-0A137FD4-3A85-4B16-9FE6-57141995E314Q38240886-0BC11125-3354-41EA-9E7C-60AD53D3A9BEQ42703872-48AB6CF7-0900-47A8-AB72-D44CCF887D62Q42909359-44CFD75A-4C9E-4047-ACE7-8B9E460941E5Q43159208-2A2C0594-8036-44A0-9604-EAE443118BA3Q46809003-555C093A-2D7A-4990-A674-33A5B1C5C6A5Q51372816-CABC827C-0D6F-4556-9613-11A5B3DC22E1
P2860
Drugs acting on serotonin receptors for the treatment of functional GI disorders.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Drugs acting on serotonin receptors for the treatment of functional GI disorders.
@ast
Drugs acting on serotonin receptors for the treatment of functional GI disorders.
@en
type
label
Drugs acting on serotonin receptors for the treatment of functional GI disorders.
@ast
Drugs acting on serotonin receptors for the treatment of functional GI disorders.
@en
prefLabel
Drugs acting on serotonin receptors for the treatment of functional GI disorders.
@ast
Drugs acting on serotonin receptors for the treatment of functional GI disorders.
@en
P2860
P356
P1433
P1476
Drugs acting on serotonin receptors for the treatment of functional GI disorders.
@en
P2093
Fabio Pace
Marcello Tonini
P2860
P356
10.1159/000090309
P577
2006-01-01T00:00:00Z